Cyclosporine 0.05% eye drops
Showing 1 - 25 of >10,000
Vernal Keratoconjunctivitis, Cyclosporine 0.05% Eye Drops Trial in Nanchang (Cyclosporine 0.05% eye drops, Loteprednol Etabonate
Completed
- Vernal Keratoconjunctivitis
- Cyclosporine 0.05% Eye Drops
- Cyclosporine 0.05% eye drops
- Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3%
-
Nanchang, Jiangxi, Chinathe Second Affiliated Hospital of Nanchang University
Apr 28, 2022
Dry Eye Trial in Beijing (artificial tear eyedrops, 0.05% cyclosporine eyedrops)
Recruiting
- Dry Eye
- artificial tear eyedrops
- 0.05% cyclosporine eyedrops
-
Beijing, Beijing, ChinaHong Qi
Sep 12, 2023
Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis Trial in Al Farwaniyah (cyclosporine A 0.05% eye drops)
Recruiting
- Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis
- cyclosporine A 0.05% eye drops
-
Al Farwānīyah, Farwanyia, KuwaitFarwanyia Hospital
Jan 31, 2023
Dry Eye Syndromes Trial in Korea, Republic of (SCAI-001 0.01% eyedrop, SCAI-001 0.02% eyedrop, Restasis 0.05% eyedrop)
Recruiting
- Dry Eye Syndromes
- SCAI-001 0.01% eyedrop
- +2 more
-
Bucheon, Korea, Republic of
- +10 more
Feb 21, 2023
GVHD in Eye Trial in Beijing (Cyclosporine, tacrolimus)
Completed
- Graft Versus Host Disease in Eye
-
Beijing, Beijing, ChinaPeking University Third Hospital
Mar 14, 2022
AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal
Completed
- Sjogren's Syndrome
- +2 more
- Autologous serum tears combined with 0.05% cyclosporin eye drop
-
Chengdu, Sichuan, ChinaHospital of Chengdu University of Traditional Chinese Medicine
Aug 25, 2023
Management of Punctal Stenosis Trial in Al Farwaniyah (0.05% cyclosporin (Restasis®, Allergan Inc), mini-monoka stent)
Completed
- Management of Punctal Stenosis
- 0.05% cyclosporin (Restasis®, Allergan Inc)
- mini-monoka stent
-
Al Farwānīyah, Farwanyia, KuwaitFarwanyia Hospital
Mar 15, 2023
Dry Eye Trial in Guangzhou (Cyclosporine, oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp
Recruiting
- Dry Eye
- Cyclosporine
- oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp biomicroscopy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Feb 9, 2022
Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)
Recruiting
- Dry Eye Disease
- 0.09% cyclosporine A ophthalmic solution
-
Waterloo, Ontario, CanadaUniversity of Waterloo
Jul 13, 2023
Ocular Surface Disease, Ocular Inflammation Trial in Rome (CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion, cationorm eye
Active, not recruiting
- Ocular Surface Disease
- Ocular Inflammation
- CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
- cationorm eye drops
-
Rome, ItalyUniversity Campus Bio Medico
Jan 5, 2022
Myopia Trial in Ho Chi Minh City (Myatro, Myatro XL)
Not yet recruiting
- Myopia
- Myatro
- Myatro XL
-
Ho Chi Minh City, VietnamUniversity Medical Center HCMC
Apr 5, 2023
Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)
Completed
- Dry Eye Disease
- CequaTM (Cyclosporine 0.09%) ophthalmic solution
-
Fort Myers, Florida
- +4 more
Sep 8, 2022
Glaucoma, Ocular Hypertensive Trial in Seoul (BRIDIN-plus Eye drops, Combigan Eye drops)
Completed
- Glaucoma
- Ocular Hypertensive
- BRIDIN-plus Eye drops
- Combigan Eye drops
-
Seoul, Seongnam, Bundang-gu, Korea, Republic ofSeungsoo Rho
Oct 9, 2023
Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry
Completed
- Dry Eye Disease
- modified hyaluronic acid 0.1% covalently linked to Riboflavin
- hyaluronic acid 0.1%
-
NAples, ItalyUniversity of Naples Federico II
Nov 2, 2023
Local Anesthetic Trial (Chloroprocaine 3% eye gel, Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops)
Not yet recruiting
- Local Anesthetic
- Chloroprocaine 3% eye gel
- Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops
- (no location specified)
Jun 27, 2023
Dry Eye Disease Trial in Andover (glycerin 0.7%/PEG 400 0.3%, polyethylene glycol 400 0.4%/propylene glycol 0.3%)
Enrolling by invitation
- Dry Eye Disease
- glycerin 0.7%/PEG 400 0.3%
- polyethylene glycol 400 0.4%/propylene glycol 0.3%
-
Andover, MassachusettsAndover Research Eye Institute
Dec 20, 2022
Dry Eye Trial in Hemet, Laguna Hills, Brecksville (Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free)
Completed
- Dry Eye
- Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free
-
Hemet, California
- +2 more
Dec 30, 2022
Healthy Volunteers Trial in Newark (Bimatoprost Ophthalmic)
Not yet recruiting
- Healthy Volunteers
- Bimatoprost Ophthalmic
-
Newark, New JerseyBiotrial
Feb 6, 2023
Progressive Myopia Trial in Netherlands (Atropine Ophthalmic 0.05%, Atropine Ophthalmic 0.5%)
Recruiting
- Progressive Myopia
- Atropine Ophthalmic 0.05%
- Atropine Ophthalmic 0.5%
-
Alkmaar, Netherlands
- +23 more
Jan 5, 2023
Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of
Completed
- Conjunctivitis, Allergic
- ADX-102 Ophthalmic Drops (0.5%)
- +2 more
-
Morrow, Georgia
- +4 more
Dec 14, 2022
Conjunctivitis, Vernal Trial in Paris (Cyclosporine NOVA22007 0.05%, Cyclosporine NOVA22007 0.1%, Vehicle)
Completed
- Conjunctivitis, Vernal
- Cyclosporine NOVA22007 0.05%
- +2 more
-
Paris, FranceGroupe Hospitalier Bichat-Claude Bernard
Nov 12, 2021
Presbyopia Trial (Phentolamine Opthalmic Solution 0.75%, Placebo, Low dose pilocarpine)
Not yet recruiting
- Presbyopia
- Phentolamine Opthalmic Solution 0.75%
- +3 more
- (no location specified)
Dec 2, 2022
Dry Eye, Dry Eye Syndromes, Cataract Trial in Brampton (dietary supplement, drug, other)
Not yet recruiting
- Dry Eye
- +2 more
- Omega-3
- +3 more
-
Brampton, Ontario, CanadaUptown Eye
Aug 6, 2023